Bone development in dogs depends on a process called endochondral ossification, where cartilage is gradually replaced by bone during growth. In dogs affected by Chondrodysplasia, mutations disrupt the normal function of genes responsible for cartilage formation and skeletal development. As a result, bones—particularly the long bones of the limbs—do not grow at a normal rate, leading to shortened legs and characteristic body structure differences.
The physical appearance of dogs with CDSL can vary depending on breed and genetic background, but common features include noticeably shorter legs, a more compact body structure, and altered limb proportions compared to non-affected dogs. In many breeds, this trait has been selectively bred for specific physical characteristics. However, in some cases, Chondrodysplasia may be associated with orthopedic challenges, including joint stress, angular limb deformities, or increased risk of intervertebral disc disease.
Clinical effects of CDSL are primarily structural rather than systemic. Most affected dogs are otherwise healthy and have normal life expectancy. However, the altered bone growth can sometimes lead to mobility issues, reduced endurance, or increased strain on joints and the spine, particularly as the dog ages or if they become overweight. The severity of these effects can vary widely depending on genetics, conformation, and lifestyle factors.
The CDSL DNA Health Test is designed to detect the specific genetic variant associated with Chondrodysplasia. Testing is simple, safe, and non-invasive, typically requiring a cheek swab or blood sample. The sample is analyzed in a specialized laboratory to determine whether the dog carries zero, one, or two copies of the mutation. Because DNA remains constant throughout life, testing can be performed at any age, including in puppies before physical traits are fully developed.
Results are generally reported as:
- Clear (Normal): The dog does not carry the CDSL mutation and will not pass it to offspring.
- Carrier: The dog carries one copy of the mutation and may show mild or intermediate physical traits depending on breed expression. It can pass the mutation to future generations.
- Affected/Positive: The dog carries two copies of the mutation and is expected to show the characteristic skeletal features associated with Chondrodysplasia.
Genetic testing for CDSL is valuable for breeders, veterinarians, and dog owners. Breeders can use results to make informed decisions about maintaining desired breed traits while reducing unintended health impacts. Understanding the genetic status of breeding dogs helps manage skeletal structure within breeding programs and supports long-term breed health and welfare.
For dog owners, knowing a dog’s CDSL status can help explain physical appearance and guide appropriate care. Dogs with pronounced limb shortening may benefit from weight management, controlled exercise, and preventive orthopedic monitoring to reduce stress on joints and the spine.
The Chondrodysplasia (CDSL) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine skeletal health awareness, and helps maintain balanced selection for physical traits while minimizing potential health risks in future generations.
